NVAX Financial Facts

Loss from operations: -63.31M
Research and development: 52.98M
See Full Income Statement

Accumulated other comprehensive income: -9.8M
Deferred rent: 1.07M
See Full Balance Sheet

Novavax, Inc. (NVAX) Earnings

  |   Expand Research on NVAX
Next EPS Date 8/10/21 *Est. EPS Growth Rate -425.9% *Last Qtr.
Average EPS % Beat Rate -16.3% Revenue Growth Rate +13,143.4% *Last Qtr.
Average % Move 1-Wk after EPS +19.0% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
5/10/21 Q121 -$3.05-$3.60 +$0.55$447.23M$233.9M N/A Details
3/1/21 Q420 -$2.70-$1.15 -$1.55$279.66M$347.92M N/A Details
11/9/20 Q320 -$3.21N/A N/A $157M$230.56M N/A Details
8/10/20 Q220 -$0.30-$0.42 +$0.12$35.54M$39.58M N/A Details
5/11/20 Q120 -$0.58-$0.78 +$0.20$3.38M$1.74M N/A Details
8/7/19 Q219 N/A-$1.61 N/A N/A$3.06M N/A N/A N/A
5/2/19 Q119 N/A-$0.11 N/A N/A$3.94M N/A N/A N/A
3/18/19 Q418 -$0.13-$0.12 -$0.01$6.1M$7.09M N/A Details